Annual Working Capital
$106.59 M
-$17.12 M-13.84%
December 31, 2023
Summary
- As of February 24, 2025, AVTE annual working capital is $106.59 million, with the most recent change of -$17.12 million (-13.84%) on December 31, 2023.
- During the last 3 years, AVTE annual working capital has risen by +$103.69 million (+3573.16%).
- AVTE annual working capital is now -37.95% below its all-time high of $171.78 million, reached on December 31, 2021.
Performance
AVTE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$80.29 M
-$13.45 M-14.35%
September 30, 2024
Summary
- As of February 24, 2025, AVTE quarterly working capital is $80.29 million, with the most recent change of -$13.45 million (-14.35%) on September 30, 2024.
- Over the past year, AVTE quarterly working capital has dropped by -$26.30 million (-24.68%).
- AVTE quarterly working capital is now -55.21% below its all-time high of $179.28 million, reached on September 30, 2021.
Performance
AVTE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
AVTE Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.8% | -24.7% |
| 3 y3 years | +3573.2% | -24.7% |
| 5 y5 years | +3631.0% | -24.7% |
AVTE Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.0% | at low | -53.3% | at low |
| 5 y | 5-year | -38.0% | +3631.0% | -55.2% | +2666.7% |
| alltime | all time | -38.0% | +3631.0% | -55.2% | +2666.7% |
Aerovate Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $80.29 M(-14.3%) |
| Jun 2024 | - | $93.74 M(+6.9%) |
| Mar 2024 | - | $87.72 M(-17.7%) |
| Dec 2023 | $106.59 M(-13.8%) | $106.59 M(-13.3%) |
| Sep 2023 | - | $122.88 M(-11.7%) |
| Jun 2023 | - | $139.19 M(+26.6%) |
| Mar 2023 | - | $109.93 M(-11.1%) |
| Dec 2022 | $123.71 M | $123.71 M(-10.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $137.45 M(-8.2%) |
| Jun 2022 | - | $149.69 M(-7.1%) |
| Mar 2022 | - | $161.18 M(-6.2%) |
| Dec 2021 | $171.78 M(+5819.5%) | $171.78 M(-4.2%) |
| Sep 2021 | - | $179.28 M(+225.3%) |
| Jun 2021 | - | $55.12 M(+604.6%) |
| Mar 2021 | - | $7.82 M(+169.5%) |
| Dec 2020 | $2.90 M(+1.6%) | $2.90 M |
| Dec 2019 | $2.86 M | - |
FAQ
- What is Aerovate Therapeutics annual working capital?
- What is the all time high annual working capital for Aerovate Therapeutics?
- What is Aerovate Therapeutics annual working capital year-on-year change?
- What is Aerovate Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Aerovate Therapeutics?
- What is Aerovate Therapeutics quarterly working capital year-on-year change?
What is Aerovate Therapeutics annual working capital?
The current annual working capital of AVTE is $106.59 M
What is the all time high annual working capital for Aerovate Therapeutics?
Aerovate Therapeutics all-time high annual working capital is $171.78 M
What is Aerovate Therapeutics annual working capital year-on-year change?
Over the past year, AVTE annual working capital has changed by -$17.12 M (-13.84%)
What is Aerovate Therapeutics quarterly working capital?
The current quarterly working capital of AVTE is $80.29 M
What is the all time high quarterly working capital for Aerovate Therapeutics?
Aerovate Therapeutics all-time high quarterly working capital is $179.28 M
What is Aerovate Therapeutics quarterly working capital year-on-year change?
Over the past year, AVTE quarterly working capital has changed by -$26.30 M (-24.68%)